BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18029060)

  • 1. [Twenty-seven years' activities of the French vasculitis study group (FVSG)].
    Guillevin L
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S263-5. PubMed ID: 18029060
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic strategies for systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Allergol Int; 2007 Jun; 56(2):105-11. PubMed ID: 17460440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current possibilities for treatment for hepatitis C virus-induced cryoglobulinemic vasculitis and B-cell lymphoma].
    Ignatova TM; Mukhin NA
    Ter Arkh; 2012; 84(11):81-8. PubMed ID: 23252255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections in vasculitis.
    Guillevin L
    Best Pract Res Clin Rheumatol; 2013 Feb; 27(1):19-31. PubMed ID: 23507054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Delluc A; Piette JC; Cacoub P
    Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
    Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis.
    Saadoun D; Rosenzwajg M; Landau D; Piette JC; Klatzmann D; Cacoub P
    Blood; 2008 Jun; 111(11):5334-41. PubMed ID: 18292291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biotherapies to treat necrotizing vasculitis].
    Guillevin L
    Rev Med Interne; 2010 Dec; 31 Suppl 3():S304-6. PubMed ID: 21055849
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of refractory and/or severe ANCA-associated systemic necrotizing vasculitides.
    Guillevin L; Pagnoux C
    Isr Med Assoc J; 2008 Jan; 10(1):89-91. PubMed ID: 18300585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of viral vasculitis].
    Lhote F; Guillevin L
    Pathol Biol (Paris); 1999 Mar; 47(3):257-64. PubMed ID: 10214619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment of severe HCV-cryoglobulinemic vasculitis with the use of CD20 monoclonalantibodies and antiviral agents].
    Ignatova TM; Chernova OA; Burnevich EZ; Milovanova SIu
    Klin Med (Mosk); 2014; 92(8):62-4. PubMed ID: 25790700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cryoglobulinemia].
    Cacoub P; Sène D; Saadoun D
    Rev Med Interne; 2008 Mar; 29(3):200-8. PubMed ID: 18242787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatitis C-virus-related glomerulonephritis.
    Kamar N; Rostaing L; Alric L
    Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis.
    Lamprecht P; Moosig F; Gause A; Herlyn K; Gross WL
    Clin Exp Rheumatol; 2000; 18(3):319-25. PubMed ID: 10895368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?
    Cacoub P; Delluc A; Saadoun D; Landau DA; Sene D
    Ann Rheum Dis; 2008 Mar; 67(3):283-7. PubMed ID: 17644544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis associated cryoglobulinemia].
    Pischke S; Cornberg M; Manns MP
    Internist (Berl); 2008 Mar; 49(3):297-304. PubMed ID: 18327517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L44. Management of relapses in vasculitis.
    Mouthon L
    Presse Med; 2013 Apr; 42(4 Pt 2):619-22. PubMed ID: 23477710
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of monoclonal antibody (rituximab) in the treatment of type II mixed cryoglobulinemia.
    Rego TC; Massumoto CM; Batista RS; Moura LH; Soares LM; Gomes AP
    Braz J Infect Dis; 2007 Feb; 11(1):174-5. PubMed ID: 17625752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoglobulinemia vasculitis: an update.
    Terrier B; Cacoub P
    Curr Opin Rheumatol; 2013 Jan; 25(1):10-8. PubMed ID: 23196322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of HCV-associated cryoglobulinemic glomerulonephritis].
    Laurino S; Borrelli S; Catapano F; Mascia S; D'Angio' P; Calabria M; Grimaldi M; Salvio A; Minutolo R; De Nicola L; Conte G
    G Ital Nefrol; 2009; 26(3):318-27. PubMed ID: 19554529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.